Three UK research councils are to invest £25 m in research and equipment to support the development of regenerative medicine therapies for a range of applications, including Parkinson’s disease, cardiovascular disease, wound and musculoskeletal repair, eye disorders and deafness.
£4.5 m will be invested in a new ‘hub’ for pluripotent stem cell research as part of the UK Regenerative Medicine Platform (UKRMP). The Hub will work with the other strands of the UKRMP to tackle some of the critical challenges in developing new regenerative treatments from discoveries made in the lab. A further £20m of capital funding from the MRC will provide facilities and equipment to support the work of the UKRMP and the wider regenerative medicine research community.
